Research programme: viral immunotherapy - Lipid Sciences
Alternative Names: Viral immunotherapy research programme - Lipid SciencesLatest Information Update: 16 Jul 2016
At a glance
- Originator Lipid Sciences
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Coronavirus infections; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Severe acute respiratory syndrome in USA
- 05 Dec 2003 Preclinical trials in HIV infections treatment in USA (unspecified route)